Loading…
Shuttle Pharmaceuticals Holdings, Inc. is projected to rise to $0.5577 by 2027, a +7% move from its current price of $0.5198. SHPH is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.4873 | $0.5199 | $0.5547 | +0.03% |
| May 30 | $0.4746 | $0.5201 | $0.57 | +0.06% |
| May 31 | $0.4651 | $0.5202 | $0.582 | +0.08% |
| Jun 1 | $0.4572 | $0.5204 | $0.5923 | +0.11% |
| Jun 2 | $0.4504 | $0.5205 | $0.6016 | +0.14% |
| Jun 3 | $0.4443 | $0.5207 | $0.6102 | +0.17% |
| Jun 4 | $0.4388 | $0.5208 | $0.6181 | +0.20% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.4388 | $0.5208 | $0.6181 | +0.20% |
| Week 2 | $0.4096 | $0.5218 | $0.6649 | +0.39% |
| Week 3 | $0.3886 | $0.5229 | $0.7035 | +0.59% |
| Week 4 | $0.3719 | $0.5239 | $0.738 | +0.79% |
| Week 5 | $0.3579 | $0.5249 | $0.7699 | +0.99% |
| Week 6 | $0.3457 | $0.526 | $0.8002 | +1.19% |
| Week 7 | $0.335 | $0.527 | $0.8292 | +1.39% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) operates as a clinical stage pharmaceutical company in the Healthcare sector. It develops novel therapies to treat cancers and owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development.
The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
Shuttle Pharmaceuticals focuses on advancing oncology programs and leveraging its AI-driven platform to support discovery and early development efforts.
SHPH is currently priced at $0.5198 per share, with a market capitalization of $3.04M and a rank of 5360 by market size. These metrics place the stock among micro-cap to nano-cap listings, highlighting the small-cap profile of the equity.
The price trajectory forecast shows a path from the current level toward higher levels over time, with a 2026 avg of $0.5198 and a 2026 max of $0.7524, then further upside in later years. By 2050, the forecast calls for an average near $2.24 and a max around $5.15, suggesting substantial uplift relative to today.
Current technicals indicate bearish near-term dynamics, while the long-run forecast projects a bullish drift with notable upside potential across the horizon, yielding a wide range of outcomes depending on year. These figures are estimates and not guarantees.
A major floor 67.9% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 102.0% above — a clean break opens room to run.
A major ceiling 381.0% above — clearing it would confirm fresh momentum.
Key SHPH support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SHPH market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.5788 | Sell | $0.5739 | Sell |
| MA 10 | $0.6139 | Sell | $0.6135 | Sell |
| MA 20 | $0.6994 | Sell | $0.6818 | Sell |
| MA 50 | $0.7992 | Sell | $0.8356 | Sell |
| MA 100 | $1.13 | Sell | $1.23 | Sell |
| MA 200 | $2.04 | Sell | $4.49 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 33.06 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -126.40 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -24.53 | Sell |
| Bollinger %B (20,2) | 0.15 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -1.22 | Sell |
| Awesome (5,34) | -0.21 | Sell |
| Ultimate (7,14,28) | 17.90 | Buy |
| Momentum (10) | -0.14 | Sell |
| Aroon Osc (25) | -80.00 | Sell |
| Hull MA (9) | 0.56 | Sell |
| ADX (14) | 21.80 | Sell |
| ATR (14) | 0.05 | Info |
The 30-day technical picture is bearish, with RSI(14) at 30, indicating cooling momentum. The stock trades below both the SMA50 ($0.7992) and the SMA200 ($2.04), reinforcing an air of weakness near the front of the price curve.
Immediate support sits at $0.52, with resistance at $1.05, framing a downside tilt on a break of support and an upside test near the resistance. The 30-day range spans from $0.3392 to $0.7965, underscoring recent volatility within a tight, low-price band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.5198 | $0.5198 | $0.7524 | 0% | Neutral | |
| $0.4013 | $0.5577 | $0.8385 | +7% | Neutral | |
| $0.5937 | $0.8754 | $1.40 | +68% | Bullish | |
| $0.5519 | $0.8566 | $1.44 | +65% | Bullish | |
| $0.4556 | $0.7411 | $1.29 | +43% | Bullish | |
| $0.4627 | $0.7863 | $1.42 | +51% | Bullish | |
| $0.3858 | $0.6838 | $1.27 | +32% | Bullish | |
| $0.3675 | $0.6782 | $1.30 | +30% | Bullish | |
| $0.4312 | $0.8278 | $1.62 | +59% | Bullish | |
| $0.4977 | $0.993 | $1.99 | +91% | Bullish | |
| $0.4234 | $0.9408 | $2.07 | +81% | Bullish | |
| $1.01 | $2.24 | $5.15 | +330% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.5198 | $0.5198 | $0.6116 | +0.00% |
| June 2026 | $0.4091 | $0.4907 | $0.6097 | -5.61% |
| July 2026 | $0.4372 | $0.5333 | $0.6797 | +8.69% |
| August 2026 | $0.4574 | $0.5654 | $0.7345 | +6.01% |
| September 2026 | $0.4239 | $0.5298 | $0.6991 | -6.29% |
| October 2026 | $0.4104 | $0.5181 | $0.6934 | -2.20% |
| November 2026 | $0.4361 | $0.5556 | $0.7525 | +7.22% |
| December 2026 | $0.4273 | $0.5492 | $0.7524 | -1.15% |
Click any year to see its month-by-month SHPH forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, SHPH could reach as high as $0.7524, with a base case around $0.5198 and support toward $0.5198 — roughly 0% from $0.5198. Price action looks broadly range-bound.
Expect SHPH to range from $0.4013 to $0.8385 through 2027. The $0.5577 average target implies a +7% move from current prices. That is up +7% on the projected 2026 average. A consolidation phase looks the most probable path here.
The SHPH price prediction for 2028 points to an average of $0.8754 (low $0.5937, high $1.40) — a potential gain of +68% on today's $0.5198. Momentum favours further upside here.
In 2029, SHPH is projected to trade between $0.5519 and $1.44, averaging $0.8566 — a potential gain of +65% from today's $0.5198. That is -2% versus the projected 2028 average. Buyers look set to stay in control over this stretch.
Shuttle Pharmaceuticals Holdings, Inc.'s 2030 outlook centres on $0.7411, within a $0.4556 to $1.29 range. That is -13% versus the projected 2029 average. That marks a +43% change versus current levels. Momentum favours further upside here.
By 2031, SHPH could reach as high as $1.42, with a base case around $0.7863 and support toward $0.4627 — roughly +51% from $0.5198. Buyers look set to stay in control over this stretch.
Expect SHPH to range from $0.3858 to $1.27 through 2032. The $0.6838 average target implies a +32% move from current prices. That is -13% versus the projected 2031 average. Momentum favours further upside here.
The SHPH price prediction for 2033 points to an average of $0.6782 (low $0.3675, high $1.30) — a potential gain of +30% on today's $0.5198. Buyers look set to stay in control over this stretch.
In 2034, SHPH is projected to trade between $0.4312 and $1.62, averaging $0.8278 — a potential gain of +59% from today's $0.5198. That is up +22% on the projected 2033 average. Momentum favours further upside here.
Shuttle Pharmaceuticals Holdings, Inc.'s 2035 outlook centres on $0.993, within a $0.4977 to $1.99 range. That is up +20% on the projected 2034 average. That marks a +91% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, SHPH could reach as high as $2.07, with a base case around $0.9408 and support toward $0.4234 — roughly +81% from $0.5198. Momentum favours further upside here.
Expect SHPH to range from $1.01 to $5.15 through 2050. The $2.24 average target implies a +330% move from current prices. That is up +138% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in SHPH today (≈ 1,923.816853 SHPH) could be worth
$4,303.69
+$3,303.69 (+330%) by 2050 · US Dollar
Based on the average projected SHPH price of $2.24 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SHPHwould be worth at today's price.
$1,000 invested in SHPH on May 27, 2025 (≈ 228.571429 SHPH) would be worth
$118.81
-$881.19 (-88.1%) today · 0.12× · US Dollar
Based on a SHPH entry price of $4.38 vs. today's $0.5198.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.593 | $876.56 | -12.3% |
| 1 month ago | $1.05 | $495.05 | -50.5% |
| 3 months ago | $1.09 | $476.88 | -52.3% |
| 6 months ago | $1.43 | $363.5 | -63.7% |
| 1 year ago | $4.38 | $118.81 | -88.1% |
| All time (3.7y) ago | $7,696 | $0.07 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SHPH forecast.
Our base-case forecast reaches $1.00 around 2050.
Implied market cap at $1.00: $5.85M
Looking out across the multi-year forecast, SHPH shows bullish potential from 2028 onward, with a sequence of higher-average prices and meaningful upside. The 2030 forecast yields an average of $0.7411 and a max of $1.29, delivering a 42.6% ROI, while remaining in a bullish sentiment.
The intermediate horizon climbs further, with 2040 projecting an average of $0.9408 and a max of $2.07, supported by an 81% ROI. By 2050 the average is expected at $2.24 with a max of $5.15, corresponding to a 330.4% ROI. Across these years, the sentiment remains BULLISH, reflecting broader uplift after the earlier neutral/more cautious periods.
The volatility backdrop is strong, with annualized volatility at 100%, highlighting substantial risk alongside potential upside. While the longer-term path looks favorable in the forecast, investors should treat these as estimates rather than guarantees and consider the near-term bearish technical backdrop when evaluating timing and risk.
Tap a question to reveal the answer.
2030 forecast: avg $0.7411, max $1.29, min $0.4556 with ROI 42.6% and sentiment BULLISH.
The multi-year forecast shows a bullish path with averages rising to $2.24 by 2050 and a max of $5.15, but near-term sentiment is mixed (2026 neutral to 2027 neutral) and volatility is high (100%). These are estimates, not guarantees.
Yes. The forecast provides multiple years with max prices above $1, including $1.40 in 2028 and $1.44 in 2029, and a $1.99 max in 2035, with even higher potential by 2040 ($2.07 max) and 2050 ($5.15 max).
Current price is $0.5198 per share. The forecasted annualized volatility is 100%, indicating a high level of price fluctuation within and across periods.
Healthcare.
Shuttle Pharmaceuticals Holdings, Inc. Community Discussion
0Share your Shuttle Pharmaceuticals Holdings, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.